| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.9 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0029 |
0.9 |